Patients randomized to high-dose edoxaban had fewer strokes on-treatment ( hazard ratio , @ ; @ % confidence interval , @-@ @ ) than warfarin ( median time-in-therapeutic range , @ % ) ; patients in the low-dose edoxaban group had similar rates ( hazard ratio , @ versus warfarin ; @ % confidence interval , @-@ @ ) .